Page last updated on July 16, 2024
Zura Bio Ltd reported their cybersecurity risk management and governance process in a yearly 10-K filed on 2024-03-28 06:03:26 EDT.
Filings
10-K filed on 2024-03-28
Zura Bio Ltd filed a 10-K at 2024-03-28 06:03:26 EDT
Accession Number: 0001410578-24-000329
Note: filing items unformatted. Drop us a note with the above URL to help us prioritize formatting it!
Item 1C. Cybersecurity.
ITEM 1C. CYBERSECURITY We are developing a cyber risk management program to identify, assess, manage, mitigate, and respond to cybersecurity threats. This program will be integrated within the Company’s enterprise risk management system. The program will address the corporate information technology environment, third-party service providers, and external-facing applications. Our cybersecurity incident response process will involve a multi-functional approach for investigating, containing, and mitigating incidents, including reporting findings to senior management and other key stakeholders, including if appropriate the audit committee and the board, and keeping them informed and involved as appropriate. While we have not, as of the date of this Form 10-K, experienced a cybersecurity threat or incident that has had a material impact on our business or operations, there can be no guarantee that we will not experience an incident that results in a material impact to our business or operations in the future. In addition, cybersecurity threats are constantly evolving and increasing in sophistication, which increases the difficulty of successfully defending against them or implementing adequate preventative measures. Our information security team, which reports to the Chief Legal Officer, stays informed about and oversees prevention, detection, mitigation, and remediation efforts through regular communication and reporting channels within our organization.
Company Information
Name | Zura Bio Ltd |
CIK | 0001855644 |
SIC Description | Biological Products, (No Diagnostic Substances) |
Ticker | ZURA - NasdaqZURAW - Nasdaq |
Website | |
Category | Emerging growth company |
Fiscal Year End | December 30 |